KOD - Kodiak Sciences Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Palo Alto,
United States
Type: Equity
KOD price evolution
KOD
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $225.41 | $252.1 | $291.83 | |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $202.49 | $224.63 | $251.51 | $289.31 |
| Long term investments | ||||
| Property, plant & equipment | $155.25 | $161.91 | $168.36 | $175.02 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $176.95 | $183.25 | $190.06 | |
| Total investments | ||||
| Total assets | $372.67 | $401.58 | $434.76 | $479.37 |
| Current liabilities | ||||
| Accounts payable | $3.29 | $1.87 | $2.48 | $13.61 |
| Deferred revenue | ||||
| Short long term debt | $9.89 | $9.61 | $9.77 | |
| Total current liabilities | $24.06 | $21.2 | $24.86 | $41.73 |
| Long term debt | $65.87 | $68.72 | $71.86 | |
| Total noncurrent liabilities | $165.87 | $168.72 | $171.86 | |
| Total debt | $75.76 | $78.32 | $81.63 | |
| Total liabilities | $187.3 | $187.07 | $193.57 | $213.59 |
| Shareholders' equity | ||||
| Retained earnings | -$1284.63 | -$1240.69 | -$1195.57 | -$1152.53 |
| Other shareholder equity | ||||
| Total shareholder equity | $214.51 | $241.19 | $265.78 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $291.83 | $196.76 | $737.83 | $950.72 |
| Short term investments | $288.5 | $24.58 | ||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $289.31 | $486 | $734.81 | $972 |
| Long term investments | ||||
| Property, plant & equipment | $175.02 | $115.75 | $108.07 | $78.81 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $190.06 | $180.62 | $169.41 | $95.34 |
| Total investments | $288.5 | $24.58 | ||
| Total assets | $479.37 | $666.63 | $904.22 | $1067.35 |
| Current liabilities | ||||
| Accounts payable | $13.61 | $9.13 | $12.43 | $8.65 |
| Deferred revenue | ||||
| Short long term debt | $9.77 | $9.93 | $3.93 | $2.37 |
| Total current liabilities | $41.73 | $52.5 | $64.68 | $31.42 |
| Long term debt | $71.86 | $77.81 | $76.06 | $75.03 |
| Total noncurrent liabilities | $171.86 | $177.97 | $176.22 | $175.17 |
| Total debt | $81.63 | $87.73 | $80 | $77.4 |
| Total liabilities | $213.59 | $230.46 | $240.9 | $206.6 |
| Shareholders' equity | ||||
| Retained earnings | -$1152.53 | -$892.04 | -$558.22 | -$291.23 |
| Other shareholder equity | -$1.31 | $0.05 | ||
| Total shareholder equity | $265.78 | $436.17 | $663.32 | $860.75 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $32.51 | $29.93 | $46.63 | |
| Selling, general & administrative | $15.47 | $16.12 | $16.75 | |
| Total operating expenses | $46.63 | $47.98 | $46.05 | $63.37 |
| Operating income | -$47.98 | -$46.05 | -$63.37 | |
| Income from continuing operations | ||||
| EBIT | -$45.12 | -$43.04 | -$59.52 | |
| Income tax expense | ||||
| Interest expense | $2.71 | |||
| Net income | ||||
| Net income | -$43.95 | -$45.12 | -$43.04 | -$59.52 |
| Income (for common shares) | -$45.12 | -$43.04 | -$59.52 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $206.3 | $267.59 | $217.34 | $107.39 |
| Selling, general & administrative | $71.02 | $73.79 | $49.71 | $28.62 |
| Total operating expenses | $277.32 | $341.38 | $267.05 | $136.01 |
| Operating income | -$277.32 | -$341.38 | -$267.05 | -$136.01 |
| Income from continuing operations | ||||
| EBIT | -$260.48 | -$333.81 | -$266.97 | -$133.07 |
| Income tax expense | ||||
| Interest expense | $0.01 | $0.02 | $0.02 | $0.03 |
| Net income | ||||
| Net income | -$260.49 | -$333.82 | -$266.99 | -$133.1 |
| Income (for common shares) | -$260.49 | -$333.82 | -$266.99 | -$133.1 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$45.12 | -$43.04 | -$59.52 | |
| Operating activities | ||||
| Depreciation | $6.68 | $6.65 | $6.66 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $18.38 | $18.41 | $22.83 | |
| Total cash flows from operations | -$26.49 | -$39.6 | -$32.24 | |
| Investing activities | ||||
| Capital expenditures | -$0.05 | -$0.02 | -$27.48 | |
| Investments | -$0.21 | -$0.14 | ||
| Total cash flows from investing | -$0.63 | -$0.26 | -$0.17 | -$27.8 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.06 | $0.04 | $0.05 | |
| Net borrowings | ||||
| Total cash flows from financing | $0.1 | $0.06 | $0.04 | -$0.12 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$87.78 | -$26.69 | -$39.73 | -$60.16 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$260.49 | -$333.82 | -$266.99 | -$133.1 |
| Operating activities | ||||
| Depreciation | $25.95 | $11 | $8.71 | $4.21 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $88.56 | $106.03 | $61.38 | $30.67 |
| Total cash flows from operations | -$154.18 | -$206.46 | -$182.27 | -$83.43 |
| Investing activities | ||||
| Capital expenditures | -$41.43 | -$47.36 | -$63.3 | -$7 |
| Investments | $290.65 | -$289.77 | $24.5 | $111.83 |
| Total cash flows from investing | $249.23 | -$336.51 | -$38.8 | $104.83 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.24 | $1.94 | $8.23 | $617.78 |
| Net borrowings | -$0.01 | |||
| Total cash flows from financing | $0.03 | $1.9 | $8.18 | $717.38 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $95.07 | -$541.08 | -$212.89 | $738.78 |
News
Fundamentals
| Market cap | $976.68M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 52.62M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$191.62M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -5.10 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$3.64 |
|---|---|
| ROA | -45.40% |
| ROE | N/A |
| Debt/Equity | 0.80 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 8.42 |
| Quick ratio | N/A |